Shelley Orwick

2.6k total citations
60 papers, 1.5k citations indexed

About

Shelley Orwick is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Shelley Orwick has authored 60 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Hematology, 34 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Shelley Orwick's work include Acute Myeloid Leukemia Research (46 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Histone Deacetylase Inhibitors Research (12 papers). Shelley Orwick is often cited by papers focused on Acute Myeloid Leukemia Research (46 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Histone Deacetylase Inhibitors Research (12 papers). Shelley Orwick collaborates with scholars based in United States, Netherlands and Malaysia. Shelley Orwick's co-authors include Sharyn D. Baker, Shuiying Hu, Alex Sparreboom, Ryan M. Franke, Eric I. Zimmerman, John C. Byrd, James S. Blachly, Hiroto Inaba, Kelly K. Filipski and Chaoxin Hu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Shelley Orwick

55 papers receiving 1.5k citations

Peers

Shelley Orwick
Ehab Atallah United States
John K. Leighton United States
Catherine Dutreix Switzerland
Peter Hellemans Belgium
Marie‐Hélène Schlageter France
Kristen M. O’Dwyer United States
Olga K. Weinberg United States
Lars Möllgård Sweden
Lise Willems France
Alberto Bessudo United States
Ehab Atallah United States
Shelley Orwick
Citations per year, relative to Shelley Orwick Shelley Orwick (= 1×) peers Ehab Atallah

Countries citing papers authored by Shelley Orwick

Since Specialization
Citations

This map shows the geographic impact of Shelley Orwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelley Orwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelley Orwick more than expected).

Fields of papers citing papers by Shelley Orwick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shelley Orwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelley Orwick. The network helps show where Shelley Orwick may publish in the future.

Co-authorship network of co-authors of Shelley Orwick

This figure shows the co-authorship network connecting the top 25 collaborators of Shelley Orwick. A scholar is included among the top collaborators of Shelley Orwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shelley Orwick. Shelley Orwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nicolet, Deedra, Daelynn R. Buelow, Shelley Orwick, et al.. (2025). Prognostic, biological, and structural implications of FLT3-JMD point mutations in acute myeloid leukemia: an analysis of Alliance studies. Leukemia. 39(3). 623–631. 1 indexed citations
2.
Kohlschmidt, Jessica, Krzysztof Mrózek, Deedra Nicolet, et al.. (2023). Association of social deprivation with survival in younger adult patients with AML: an Alliance study. Blood Advances. 7(15). 4019–4023. 5 indexed citations
3.
Mrózek, Krzysztof, Jessica Kohlschmidt, James S. Blachly, et al.. (2023). Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study. Leukemia. 37(4). 788–798. 31 indexed citations
4.
Bhatnagar, Bhavana, Jessica Kohlschmidt, Shelley Orwick, et al.. (2023). Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study. Blood Advances. 7(16). 4671–4675. 1 indexed citations
5.
Eisenmann, Eric D., Kevin M. Huang, Daelynn R. Buelow, et al.. (2022). TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers. 15(1). 29–29. 7 indexed citations
6.
Özer, Hatice Gülçin, Arletta Lozanski, Shelley Orwick, et al.. (2022). Clonal hematopoiesis of indeterminate potential in the companion dog. Leukemia. 36(5). 1401–1403. 3 indexed citations
7.
Buelow, Daelynn R., Bhavana Bhatnagar, Shelley Orwick, et al.. (2022). BMX kinase mediates gilteritinib resistance inFLT3-mutated AML through microenvironmental factors. Blood Advances. 6(17). 5049–5060. 7 indexed citations
8.
Walker, Alison R., John C. Byrd, James S. Blachly, et al.. (2020). Entospletinib in Combination with Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of HOXA9 and MEIS1 Expression. Clinical Cancer Research. 26(22). 5852–5859. 27 indexed citations
9.
Buelow, Daelynn R., Mingshan Niu, Eric D. Eisenmann, et al.. (2020). TP-0903 is active in models of drug-resistant acute myeloid leukemia. JCI Insight. 5(23). 21 indexed citations
10.
Brinton, Lindsey T., Pu Zhang, Katie Williams, et al.. (2020). Synergistic effect of BCL2 and FLT3 co-inhibition in acute myeloid leukemia. Journal of Hematology & Oncology. 13(1). 139–139. 37 indexed citations
11.
Gregory, Charles T., Apollinaire Ngankeu, Shelley Orwick, et al.. (2020). Characterization and mitigation of fragmentation enzyme-induced dual stranded artifacts. NAR Genomics and Bioinformatics. 2(4). lqaa070–lqaa070. 6 indexed citations
12.
13.
14.
Eisfeld, Ann‐Kathrin, Jessica Kohlschmidt, Krzysztof Mrózek, et al.. (2016). Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality. Cancer Research. 77(1). 207–218. 16 indexed citations
15.
Zimmerman, Eric I., Alice A. Gibson, Shuiying Hu, et al.. (2016). Multikinase Inhibitors Induce Cutaneous Toxicity through OAT6-Mediated Uptake and MAP3K7-Driven Cell Death. Cancer Research. 76(1). 117–126. 38 indexed citations
16.
Baker, Sharyn D., Eric I. Zimmerman, Yong‐Dong Wang, et al.. (2013). Emergence of Polyclonal FLT3 Tyrosine Kinase Domain Mutations during Sequential Therapy with Sorafenib and Sunitinib in FLT3-ITD–Positive Acute Myeloid Leukemia. Clinical Cancer Research. 19(20). 5758–5768. 75 indexed citations
17.
Zimmerman, Eric I., Shuiying Hu, Alice A. Gibson, et al.. (2013). Contribution of OATP1B1 and OATP1B3 to the Disposition of Sorafenib and Sorafenib-Glucuronide. Clinical Cancer Research. 19(6). 1458–1466. 131 indexed citations
18.
Lancaster, Cynthia S., Chaoxin Hu, Ryan M. Franke, et al.. (2010). Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine Wasting. Clinical Cancer Research. 16(19). 4789–4799. 43 indexed citations
19.
Hu, Shuiying, Zhaoyuan Chen, Ryan M. Franke, et al.. (2009). Interaction of the Multikinase Inhibitors Sorafenib and Sunitinib with Solute Carriers and ATP-Binding Cassette Transporters. Clinical Cancer Research. 15(19). 6062–6069. 129 indexed citations
20.
Hu, Shuiying, Hongmei Niu, Shelley Orwick, et al.. (2008). Comparison of antitumor effects of multitargeted tyrosine kinase inhibitors in acute myelogenous leukemia. Molecular Cancer Therapeutics. 7(5). 1110–1120. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ehab Atallah Breakdown of academic impact, for papers by John K. Leighton Breakdown of academic impact, for papers by Catherine Dutreix Breakdown of academic impact, for papers by Peter Hellemans Breakdown of academic impact, for papers by Marie‐Hélène Schlageter Breakdown of academic impact, for papers by Kristen M. O’Dwyer Breakdown of academic impact, for papers by Olga K. Weinberg Breakdown of academic impact, for papers by Lars Möllgård Breakdown of academic impact, for papers by Lise Willems Breakdown of academic impact, for papers by Alberto Bessudo
Rankless by CCL
2026